News from NPPG September 2025

Click the headings to reveal the content. Click again to close

Welcome to the first edition of the NPPG Newsletter in its new format—designed in response to your survey feedback to bring all important updates into one accessible space. Whether you’re working as a clinical specialist, on the ward, in dispensary, or supporting services behind the scenes, we hope is this newsletter helps you stay connected, informed, and inspired.

In this debut issue, you’ll find essential medicine supply alerts (such as notice on Abidec® multivitamin drops and guidance on switching between modified-release methylphenidate). There are also interesting articles like “Paediatric rare diseases: Can large language models assist off-label prescribing?” and a systematic review on the use of intravenous magnesium sulfate in acute asthma management in children. Alongside these is a snapshot piece—Sixty seconds on… melatonin gummies—and the newly available Antimicrobial Paediatric Guide (UK-PAS).

You’ll also find recent message board discussions (covering topics from unlicensed medication alternatives to NICU chlorhexidine use), recent education sessions (such as Credentialing or Constipation in children), plus committee highlights and our social media connections.

NPPG is also refreshing its approach to equity, diversity, and inclusion; as part of that we are updating our Inclusivity and Diversity Statement and are hosting an unconscious bias session with Amandeep Doll from the RPS. This session will explore how bias can shape interactions, influence decisions, and impact care, helping to build a more inclusive paediatric pharmacy culture where everyone feels valued and supported..

I hope you find this new format both practical and inspiring—and that it supports you in all the work you do each day.

Nanna Christiansen

In line with the current Neonatal and Paediatric Pharmacy Group terms of reference we inform you that the following committee members are coming to the end of their term on the NPPG Organising Committee in November this year.

  • Ashifa Trivedi
  • Andrea Gill
  • Sian Gaze
  • Neil Caldwell.

All candidates can stand for another term of office from December 2025 – November 2028. There are 5 available posts on the NPPG elected committee starting this year.

The Neonatal and Paediatric Pharmacists Group is built on the enthusiasm and contributions of its members, and our committee is at its best when a wide range of voices and experiences are represented. Joining the Organising Committee is a fantastic way to get more involved, share ideas, and help shape the future of the NPPG and our profession. You don’t need to have sat on a committee before – what matters most is your passion for improving care for children, and your willingness to work with colleagues from across the UK.

If you’ve ever thought about taking a more active role in NPPG, this is the perfect opportunity – we’d love to see applications from across our membership, whatever your background or level of experience.

Please complete the below form to express your interest for a place on the NPPG.

https://eu.jotform.com/build/251833868630363

Deadline for submission: 5pm Wednesday 15th October.

Should we receive more than 5 total applications for a position as an NPPG committee member, then a ballot of NPPG members will take place between Monday 20th October and Monday 3rd November.

The results of any ballot will be announced at the NPPG AGM, taking place on Saturday 15th November at the NPPG Conference in Newcastle, 1.35pm.

NPPG welcome applications from all their members.

To bring attention to this critical issue, “Safe care for every newborn and every child” has been selected as the theme for World Patient Safety Day 2025, emphasising the need for stronger measures to protect children from preventable harm. Click the image above to go to the WHO site

Keeping Children Safe with Medicines – Everyone’s Responsibility

World Patient Safety Day 2025

By Chloe Benn, Consultant Paediatric Pharmacist, Vice Chair of the Neonatal and Paediatric Pharmacists Group (NPPG)

This year’s World Patient Safety Day theme, “Safe care for every newborn and every child”, reminds us that medicines safety is particularly important in children. Newborns and children are especially vulnerable to errors – their bodies handle medicines differently, doses are often weight-based, and many medicines are unlicensed or used off-label.

Safe and effective use of medicines in children requires specialist knowledge, standardised processes, and clear communication with families.

Why it matters

NPPG works closely with National organisations including the RCPCH to set shared priorities for safer children’s medicines:

  • Improving the safety of unlicensed and off-label medicines
  • Reducing medication errors through standardisation of products & processes
  • Supporting safer transitions of care, such as hospital discharge
  • Enhancing child-friendly formulations
  • Involving children and families in decisions about their medicines

A real-life example

A young child with epilepsy was discharged on a liquid medicine at 5 mg/ml. The community pharmacy inadvertently supplied a 10 mg/ml strength. The family continued giving the same volume, effectively doubling the dose. The child became unwell and needed hospital admission.

Thankfully they recovered, but this illustrates the risks of variable liquid strengths. National work led by NPPG, RCPCH, and the BNF for Children is helping to prevent such incidents through standardisation of concentrationsand clearer labelling. Standardised strengths of liquid medicines for children – NPPGStandardised Infusions – NPPG

NPPG statement on standardised labelling

Medicines safety depends not only on the right medicine and dose, but also on the clarity of the information families receive. Confusing or inconsistent labels can increase the risk of error, especially where multiple strengths or formulations exist.

The NPPG statement on standardised labelling of oral medicines calls for:

  1. For liquid medicines, the dose is expressed in millilitres (mL) only, (not both mg & ml & never mg only).
  2. For solid dosage forms, the dose is expressed as the number of tablets or capsules to be taken, numericallyrather than in words, e.g. “1 capsule” not “one capsule”
  3. The dosing frequency is expressed in words as the number of times “a day” the medicine should be taken, e.g.: “ONCE a day” or “FOUR times a day”.

Labelling of Dispensed Oral Medicines for Children position statement – NPPG

By aligning practice nationally, we can reduce misunderstandings and support both families and healthcare professionals to give medicines safely. Clearer labelling also supports wider safety initiatives such as standardised concentrations and improved discharge communication.

Supporting families

Parents and carers give most doses at home. They can help prevent harm by:

  • Asking what the medicine is for, what strength, and how to give it
  • Checking labels carefully, especially after discharge
  • Using oral syringes & dedicated medicines measures rather than teaspoons
  • Keeping a record of doses and side effects
  • Using trusted resources like Medicines for Children (https://www.medicinesforchildren.org.uk/) or the My Child’s Meds app

Moving forward

Medicines save lives – but only when used safely. By reflecting, speaking up, and empowering families, we can create a safer system for every child.

On this World Patient Safety Day, let’s reaffirm our commitment: every child deserves medicines use that is effective, safe, and tailored to their needs.

Chloe Benn
Consultant Paediatric Pharmacist Barts Health
Vice Chair, Neonatal and Paediatric Pharmacists Group (NPPG)

We are continuing to strengthen our EDI work across the network. Current priorities include updating the EDI statement, sharing member experiences to highlight diverse perspectives, and demonstrating our ongoing commitment to inclusive practice.

See the full details at https://nppg.org.uk/equality-diversity-and-inclusion/

Contributions from members are always welcome, and we encourage you to share your insights and suggestions with us by emailing: ashifa.trivedi@nhs.net

The RCPCH are starting to produce a regular Patient Safety Bulletin for their members.
This is not intended to be a resource just for RCPCH members, and there is value highlighting to NPPG members as it comes out, both via the website and by email. You can read the latest one here

Key

BSL – Bite Sized Learning

Upcoming sessions, and how to register  here

The District General Hospital (DGH) group has been working on some exciting projects to support colleagues in practice. Current projects include developing an e-learning module for drug histories and medicines reconciliation in paediatrics, creating staffing standards, and bite-sized learning to make training more accessible. There are plenty of opportunities to get involved, so please do reach out if you would like to contribute. You can join the group via:https://networks.nhs.uk/groups/district-general-hospital-sig-for-the-nppg/

It has been a busy period reviewing abstracts for the NPPG conference. We are excited to see the wide range of work being presented this year, showcasing the innovation and dedication across our membership. We look forward to sharing highlights in the next issue.

NPPG has various social media outlets. These are updated regularly with news and information. They are as follows (click the name to access);